Panacea Biotec Ltd (PANACEABIO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 622974, "name": "Panacea Biotec", "stock_name": "Panacea Biotec", "full_name": "Panacea Biotec Ltd", "name_url": "stocks-analysis/panacea-biotec", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "388.15", "chg": -16.85, "chgp": "-4.16%", "dir": -1, "prev_price": "405.00", "mcapval": "2,423.00 Cr", "mcap": "Small Cap", "scripcode": 531349, "symbol": "PANACEABIO", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE922B01023", "curr_date": "May 08", "curr_time": "", "bse_nse_vol": "1.02 lacs", "exc_status": "Active", "traded_date": "May 08, 2026", "traded_date_str": "2026 05 08", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/panacea-biotec-622974-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Panacea Biotec Gains 4.29%: 3 Key Factors Driving This Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-gains-429-3-key-factors-driving-this-weeks-momentum-3983507", "imagepath": "", "date": "2026-05-09 16:08:25", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>4 May:</strong> Week opens at Rs.372.20</p>\n <p><strong>6 May:</strong> Intraday high surge to Rs.393.30 (+7.12%)</p>\n <p><strong>7 May:</strong> Technical rebound with 1.57% gain to Rs.405.00</p>\n <p><strong>8 May:</strong> Mojo Score upgraded to Sell; stock closes at Rs.388.15 (-4.16%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.372.20</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.388.15</div><div class=\"stat-change p..." }, { "title": "Panacea Biotec Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals", "link": "https://www.marketsmojo.com/news/stock-recommendation/panacea-biotec-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-3980936", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PanaceaBiotecLt_mojoScore_3980936.png", "date": "2026-05-08 08:14:09", "description": "Panacea Biotec Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook despite persistent fundamental challenges. The upgrade, effective from 07 May 2026, is driven primarily by improvements in technical indicators, while valuation and financial trends remain subdued. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced this rating change." }, { "title": "Panacea Biotec Ltd Shows Signs of Technical Rebound Amid Mixed Momentum Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-ltd-shows-signs-of-technical-rebound-amid-mixed-momentum-signals-3980738", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PanaceaBiotecLt_technicaldot_3980738.png", "date": "2026-05-08 08:03:11", "description": "Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend on the weekly charts. Despite a modest daily gain of 1.57%, the stock’s technical indicators present a nuanced picture, with some metrics signalling strength while others suggest caution for investors." }, { "title": "Panacea Biotec Ltd Surges 7.12% to Day's High of Rs 393.3 — Outperforms Sector by 4.57 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-ltd-hits-intraday-high-with-712-surge-on-6-may-2026-3977829", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PanaceaBiotecLt_priceRelatedfactors_3977829.png", "date": "2026-05-06 11:30:57", "description": "The Sensex edged up 0.23% on 6 May 2026, while Panacea Biotec Ltd surged 7.12%, outperforming its Pharmaceuticals & Biotechnology sector by 4.57 percentage points. This sharp single-session gain rewrites the short-term narrative for the small-cap stock, which touched an intraday high of Rs 393.3, marking a notable move within a broader mixed market backdrop." }, { "title": "Panacea Biotec Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/panacea-biotec-ltd-is-rated-strong-sell-3972143", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PanaceaBiotecLt_mojoScore_3972143.png", "date": "2026-05-01 10:10:17", "description": "Panacea Biotec Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 31 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 May 2026, providing investors with an up-to-date view of the company’s performance and outlook." }, { "title": "Panacea Biotec Ltd Surges 7.29% to Day's High of Rs 373.55 — Outperforms Sector by 7.35 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-ltd-hits-intraday-high-with-729-surge-on-22-apr-2026-3957605", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PanaceaBiotecLt_priceRelatedfactors_3957605.png", "date": "2026-04-22 12:15:57", "description": "While the Sensex declined by 0.81% on 22 Apr 2026, Panacea Biotec Ltd surged 7.29%, marking a remarkable outperformance of 7.35 percentage points over its Pharmaceuticals & Biotechnology sector. This sharp intraday gain rewrites the short-term narrative for the stock, which had been under pressure in recent sessions." }, { "title": "Panacea Biotec Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/panacea-biotec-ltd-is-rated-strong-sell-3953864", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PanaceaBiotecLt_mojoScore_3953864.png", "date": "2026-04-20 10:10:26", "description": "Panacea Biotec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 31 October 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 20 April 2026, providing investors with an up-to-date view of the company's performance and outlook." }, { "title": "Panacea Biotec Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-ltd-technical-momentum-shifts-amid-mixed-market-signals-3946609", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PanaceaBiotecLt_technicaldot_3946609.png", "date": "2026-04-15 08:02:51", "description": "Panacea Biotec Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent upgrade in its Mojo Grade to Strong Sell from Sell, the stock’s price action and technical indicators reveal a landscape of cautious optimism tempered by persistent downside risks." }, { "title": "Panacea Biotec Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/panacea-biotec-ltd-is-rated-strong-sell-3939453", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PanaceaBiotecLt_mojoScore_3939453.png", "date": "2026-04-09 10:10:18", "description": "Panacea Biotec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 31 Oct 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 April 2026, providing investors with the latest insights into its performance and outlook." } ], "total": 251, "sid": "622974", "stock_news_url": "https://www.marketsmojo.com/news/panacea-biotec-622974" }, "announcements": [ { "caption": "Details Of Shares Dematerialized During April 2026 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations 2018", "datetime": "07-May-2026", "details": "Please find enclosed herewith the details of shares dematerialised during April 2026 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018", "source": "BSE" }, { "caption": "Intimation Of Fire Incident At Oncology Facility Of The CompanyS Wholly Owned Subsidiary Panacea Biotec Pharma Limited At Baddi Himachal Pradesh", "datetime": "30-Apr-2026", "details": "This is to inform you that a fire incident occurred on 30.04.2026 due to short circuit at the Oncology Control Laboratory of the Companys wholly owned subsidiary Panacea Biotec Pharma Ltd. at Baddi Himachal Pradesh. A requisite disclosure as required under Regulation 30 of the SEBI LODR Regulations read with SEBI Master Circular dated 30.01.2026 is attached herewith.", "source": "BSE" }, { "caption": "Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015", "datetime": "30-Apr-2026", "details": "We would like to inform you that the Income Tax Appellate Tribunal (ITAT) vide its Order dated 29.04.2026 allowed the appeal filed by the Company and set aside the Order dated 14.08.2025 of Commissioner of Income Tax (Appeals). The said Order effectively results in deletion of the disallowances of expenses as well as cancellation of demand of Rs.9.16 Crore. A detailed disclosure as required under Regulation 30 of SEBI LODR Regulations read with SEBI Master Circular dated 30.01.2026 and Industry Standards is attached herewith.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Panacea Biotec Ltd has declared <strong>75%</strong> dividend, ex-date: 19 Sep 11", "dt": "2011-09-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

4 May: Week opens at Rs.372.20

6 May: Intraday high surge to Rs.393.30 (+7.12%)

7 May: Technical rebound with 1.57% gain to Rs.405.00

8 May: Mojo Score upgraded to Sell; stock closes at Rs.388.15 (-4.16%)

Read full news article

Panacea Biotec Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-05-08 08:14:09

Panacea Biotec Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook despite persistent fundamental challenges. The upgrade, effective from 07 May 2026, is driven primarily by improvements in technical indicators, while valuation and financial trends remain subdued. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced this rating change.

Read full news article

Panacea Biotec Ltd Shows Signs of Technical Rebound Amid Mixed Momentum Signals

2026-05-08 08:03:11

Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend on the weekly charts. Despite a modest daily gain of 1.57%, the stock’s technical indicators present a nuanced picture, with some metrics signalling strength while others suggest caution for investors.

Read full news article

Panacea Biotec Ltd Surges 7.12% to Day's High of Rs 393.3 — Outperforms Sector by 4.57 Percentage Points

2026-05-06 11:30:57

The Sensex edged up 0.23% on 6 May 2026, while Panacea Biotec Ltd surged 7.12%, outperforming its Pharmaceuticals & Biotechnology sector by 4.57 percentage points. This sharp single-session gain rewrites the short-term narrative for the small-cap stock, which touched an intraday high of Rs 393.3, marking a notable move within a broader mixed market backdrop.

Read full news article

Panacea Biotec Ltd is Rated Strong Sell

2026-05-01 10:10:17

Panacea Biotec Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 31 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Panacea Biotec Ltd Surges 7.29% to Day's High of Rs 373.55 — Outperforms Sector by 7.35 Percentage Points

2026-04-22 12:15:57

While the Sensex declined by 0.81% on 22 Apr 2026, Panacea Biotec Ltd surged 7.29%, marking a remarkable outperformance of 7.35 percentage points over its Pharmaceuticals & Biotechnology sector. This sharp intraday gain rewrites the short-term narrative for the stock, which had been under pressure in recent sessions.

Read full news article

Panacea Biotec Ltd is Rated Strong Sell

2026-04-20 10:10:26

Panacea Biotec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 31 October 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 20 April 2026, providing investors with an up-to-date view of the company's performance and outlook.

Read full news article

Panacea Biotec Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-04-15 08:02:51

Panacea Biotec Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent upgrade in its Mojo Grade to Strong Sell from Sell, the stock’s price action and technical indicators reveal a landscape of cautious optimism tempered by persistent downside risks.

Read full news article

Panacea Biotec Ltd is Rated Strong Sell

2026-04-09 10:10:18

Panacea Biotec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 31 Oct 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 April 2026, providing investors with the latest insights into its performance and outlook.

Read full news article